P75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease

Molecular Psychiatry

Volumn 20, Issue 11, 2015, Pages 1301-1310

  Yao, X Q ^a   Jiao, S S ^a   Saadipour, K ^b   Zeng, F ^a   Wang, Q H ^a   Zhu, C ^a   Shen, L L ^a   Zeng, G H ^a   Liang, C R ^a   Wang, J ^a   Liu, Y H ^a   Hou, H Y ^c   Xu, X ^a   Su, Y P ^d   Fan, X T ^d   Xiao, H L ^a   Lue, L F ^e   Zeng, Y Q ^f   Giunta, B ^c   Zhong, J H ^b   Walker, D G ^e   Zhou, H D ^a   Tan, J ^c   Zhou, X F ^b,f   Wang, Y J ^a   more..

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e SUN HEALTH RESEARCH INSTITUTE   (United States)

^f KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; NEUROTROPHIN RECEPTOR P75; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; AMYLOID PRECURSOR PROTEIN; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGFR PROTEIN, HUMAN; PRESENILIN 1; RECOMBINANT PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTOSIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC SPINE; FEMALE; GLIOSIS; HUMAN; LEARNING; MALE; MEMORY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; AGE; ANIMAL; BRAIN; CASE CONTROL STUDY; CHEMISTRY; COGNITION DISORDERS; COMPLICATION; DEFICIENCY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; GENETIC TRANSDUCTION; GENETICS; MAZE TEST; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE;

ADAM PROTEINS; ADAM17 PROTEIN; AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; BRAIN; CASE-CONTROL STUDIES; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; MAZE LEARNING; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; PRESENILIN-1; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, NERVE GROWTH FACTOR; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

EID: 84946500159     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.49     Document Type: Article

References (48)

1. Rafii MS. Update on Alzheimer's disease therapeutics. Rev Recent Clin Trials 2013; 8: 110-118.
2. Castellani RJ, Perry G. Pathogenesis and disease-modifying therapy in Alzheimer's disease: The flat line of progress. Arch Med Res 2012; 43: 694-698.
3. Garzon DJ, Fahnestock M. Oligomeric amyloid decreases basal levels of brainderived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 2007; 27: 2628-2635.
4. Pedraza CE, Podlesniy P, Vidal N, Arevalo JC, Lee R, Hempstead B et al. Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Am J Pathol 2005; 166: 533-543.
5. Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 2005; 93: 1412-1421.
6. Cattaneo A, Calissano P. Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis. Mol Neurobiol 2012; 46: 588-604.
7. Dechant G, Barde YA. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 2002; 5: 1131-1136.
8. Capsoni S, Tiveron C, Vignone D, Amato G, Cattaneo A. Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration. Proc Natl Acad Sci USA 2010; 107: 12299-12304.
9. Fahnestock M, Michalski B, Xu B, Coughlin MD. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 2001; 18: 210-220.
10. Hu XY, Zhang HY, Qin S, Xu H, Swaab DF, Zhou JN. Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol 2002; 178: 104-111.
11. Mufson EJ, Kordower JH. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc Natl Acad Sci USA 1992; 89: 569-573.
12. Saadipour K, Yang M, Lim Y, Georgiou K, Sun Y, Keating D et al. Amyloid beta 1-42 (Abeta42) up-regulates the expression of sortilin via the p75(NTR)/RhoA signaling pathway. J Neurochem 2013; 127: 152-162.
13. Tiveron C, Fasulo L, Capsoni S, Malerba F, Marinelli S, Paoletti F et al. ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice. Cell Death Differ 2013; 20: 1017-1030.
14. Chao MV, Bothwell MA, Ross AH, Koprowski H, Lanahan AA, Buck CR et al. Gene transfer and molecular cloning of the human NGF receptor. Science 1986; 232: 518-521.
15. Chao MV. Hempstead BL. p75 and Trk: A two-receptor system. Trends Neurosci 1995; 18: 321-326.
16. Zampieri N, Chao MV. Mechanisms of neurotrophin receptor signalling. Biochem Soc Trans 2006; 34: 607-611.
17. Frade JM, Rodriguez-Tebar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996; 383: 166-168.
18. Singh KK, Park KJ, Hong EJ, Kramer BM, Greenberg ME, Kaplan DR et al. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat Neurosci 2008; 11: 649-658.
19. Ibanez CF, Simi A. p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci 2012; 35: 431-440.
20. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004; 427: 843-848.
21. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002; 420: 74-78.
22. Yaar M, Zhai S, Fine RE, Eisenhauer PB, Arble BL, Stewart KB et al. Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem 2002; 277: 7720-7725.
23. Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE et al. Binding of betaamyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest 1997; 100: 2333-2340.
24. Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ. Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J Neurosci 2008; 28: 3941-3946.
25. Zampieri N, Xu CF, Neubert TA, Chao MV. Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains. J Biol Chem 2005; 280: 14563-14571.
26. Urra S, Escudero CA, Ramos P, Lisbona F, Allende E, Covarrubias P et al. TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal gamma-secretase-mediated release of the p75 intracellular domain. J Biol Chem 2007; 282: 7606-7615.
27. Weskamp G, Schlondorff J, Lum L, Becherer JD, Kim TW, Saftig P et al. Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem 2004; 279: 4241-4249.
28. Wang YJ, Wang X, Lu JJ, Li QX, Gao CY, Liu XH et al. p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain. J Neurosci 2011; 31: 2292-2304.
29. del Valle J, Bayod S, Camins A, Beas-Zarate C, Velazquez-Zamora DA, Gonzalez-Burgos I et al. Dendritic spine abnormalities in hippocampal CA1 pyramidal neurons underlying memory deficits in the SAMP8 mouse model of Alzheimer's disease. J Alzheimers Dis 2012; 32: 233-240.
30. Kommaddi RP, Thomas R, Ceni C, Daigneault K, Barker PA. Trk-dependent ADAM17 activation facilitates neurotrophin survival signaling. FASEB J 2011; 25: 2061-2070.
31. Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA et al. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology 2009; 73: 1662-1669.
32. Buggia-Prevot V, Sevalle J, Rossner S, Checler F. NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. J Biol Chem 2008; 283: 10037-10047.
33. Guglielmotto M, Monteleone D, Giliberto L, Fornaro M, Borghi R, Tamagno E et al. Amyloid-beta(4)(2) activates the expression of BACE1 through the JNK pathway. J Alzheimers Dis 2011; 27: 871-883.
34. Chami L, Buggia-Prevot V, Duplan E, Delprete D, Chami M, Peyron JF et al. Nuclear factor-kappaB regulates betaAPP and beta-and gamma-secretases differently at physiological and supraphysiological Abeta concentrations. J Biol Chem 2012; 287: 24573-24584.
35. Costantini C, Weindruch R, Della Valle G, Puglielli L. A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem J 2005; 391: 59-67.
36. Chakravarthy B, Menard M, Ito S, Gaudet C, Dal Pra I, Armato U et al. Hippocampal membrane-associated p75NTR levels are increased in Alzheimer's disease. J Alzheimers Dis 2012; 30: 675-684.
37. Wang YJ, Zeng F, Yao X, Yi X, Cao H, Wang X et al. POS-THU-111: The relationship between single nucleotide polymorphisms within the NGFR gene and sporadic Alzheimer's disease in a Chinese Han population. 2014 Meeting of the Australasian Neuroscience Society: Adelaide, Australasian Neuroscience Society Inc.: Kent Town, SA, Australia, 2014; pp 126.
38. Hefti F, Mash DC. Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease. Neurobiol Aging 1989; 10: 75-87.
39. Torres JM, Javier Naves F, Esteban I, Del Valle ME, Vega JA. Neurotrophin receptor proteins immunoreactivity in the rat cerebellar cortex as a function of age. Mech Ageing Dev 1995; 83: 1-9.
40. Zhou XF, Rush RA, McLachlan EM. Differential expression of the p75 nerve growth factor receptor in glia and neurons of the rat dorsal root ganglia after peripheral nerve transection. J Neurosci 1996; 16: 2901-2911.
41. Ladiwala U, Lachance C, Simoneau SJ, Bhakar A, Barker PA, Antel JP. p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J Neurosci 1998; 18: 1297-1304.
42. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron 2001; 32: 177-180.
43. Ito S, Menard M, Atkinson T, Gaudet C, Brown L, Whitfield J et al. Involvement of insulin-like growth factor 1 receptor signaling in the amyloid-beta peptide oligomers-induced p75 neurotrophin receptor protein expression in mouse hippocampus. J Alzheimers Dis 2012; 31: 493-506.
44. Zeng F, Lu JJ, Zhou XF, Wang YJ. Roles of p75NTR in the pathogenesis of Alzheimer's disease: A novel therapeutic target. Biochem Pharmacol 2011; 82: 1500-1509.
45. Wang YJ, Valadares D, Sun Y, Wang X, Zhong JH, Liu XH et al. Effects of proNGF on neuronal viability, neurite growth and amyloid-beta metabolism. Neurotox Res 2010; 17: 257-267.
46. Yan J, Zhou X, Guo JJ, Mao L, Wang YJ, Sun J et al. Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro. J Neurochem 2012; 120: 721-731.
47. Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, Ragagnin A et al. PDK1 decreases TACE-mediated alpha-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat Med 2013; 19: 1124-1131.
48. Wang YJ. Alzheimer disease: Lessons from immunotherapy for Alzheimer disease. Nat Rev Neurol 2014; 10: 188-189.